Effectiveness of Combination between Diflucortolone Valerate and Vitamin D3 Analogue in the Treatment of Psoriasis Vulgaris

Nishinihon Journal of Dermatology

Volumn 66, Issue 2, 2004, Pages 188-191

  Tokura, Yoshiki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; BETAMETHASONE; CALCIPOTRIOL; ROXITHROMYCIN; ULOBETASOL PROPIONATE;

ARTICLE; CELL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 1942485387     PISSN: 03869784     EISSN: None     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.66.188     Document Type: Article

References (4)

1. Barker JNW et al: Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind. dose-finding study with active comparator. Br J Dermatol 141: 274-278, 1999.
2. Lebwohl M et al: A multicenter trial of calcipotrien ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 35: 268-269, 1996.
3. Ruzicka T, Lorenz B: Comparison of calcipotriol monotherapy and a combinaion of calcipotriol and betamethasone valerate after 2 week's treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 138: 254-258, 1998.
4. Ohshima A, Takigawa M, Tokura Y: CD8+ cell changes in psoriasis associated with roxithromycin-induced clinical improvement. Eur J Dermatol 11: 410-415, 2001.